Research & Literature

Mouse models of autoimmune diseases - autoimmune myocarditis.

Muller AM, Fischer A, Katus HA, Kaya Z

Current pharmaceutical design 2015; (21(18)):2498-512 doi:10.2174/1381612821666150316123711.

Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee.

Fang JC, Ewald GA, Allen LA, et al.

Journal of cardiac failure 2015; (21(6)):519-34.

Intravenous immunoglobulin for presumed viral myocarditis in children and adults.

Robinson J, Hartling L, Vandermeer B, Klassen TP

The Cochrane database of systematic reviews 2015; CD004370 doi:10.1002/14651858.CD004370.pub3.

Influence of different aetiologies on clinical course and outcome in patients with dilated cardiomyopathy.

Pankuweit S, Lüers C, Richter A, et al.

European journal of clinical investigation 2015; (45(9)):906-17 doi:10.1111/eci.12483.

Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.

Hashim T, Sanam K, Revilla-Martinez M, et al.

Circulation. Heart failure 2015; (8(5)):880-6 doi:10.1161/CIRCHEARTFAILURE.114.001778.

New strict left bundle branch block criteria reflect left ventricular activation differences.

Emerek K, Risum N, Hjortshøj S, et al.

Journal of electrocardiology 2015; (48(5)):758-62.

New-onset left bundle branch block-associated idiopathic nonischemic cardiomyopathy and left ventricular ejection fraction response to guideline-directed therapies: The NEOLITH study.

Wang NC, Singh M, Adelstein EC, et al.

Heart rhythm 2016; (13(4)):933-42.

Update on Myocarditis and Inflammatory Cardiomyopathy: Reemergence of Endomyocardial Biopsy.

Dominguez F, Kühl U, Pieske B, et al.

Revista espanola de cardiologia (English ed.) 2016; (69(2)):178-87.

Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.

Acharya D, Sanam K, Revilla-Martinez M, et al.

The American journal of cardiology 2016; (117(6)):952-6.

Viral myocarditis.

Rose NR

Current opinion in rheumatology 2016; (28(4)):383-9 doi:10.1097/BOR.0000000000000303.

Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy.

Escher F, Kühl U, Lassner D, et al.

Clinical research in cardiology : official journal of the German Cardiac Society 2016; (105(12)):1011-1020 doi:10.1007/s00392-016-1011-z.

Use of the Wearable Cardioverter Defibrillator in High-Risk Populations.

Lamichhane M, Safadi A, Surapaneni P, et al.

Current cardiology reports 2016; (18(8)):78 doi:10.1007/s11886-016-0746-5.

Role of Durable Mechanical Circulatory Support for the Management of Advanced Heart Failure.

Waqas M, Cowger JA

Heart failure clinics 2016; (12(3)):399-409.

Inflammatory Cardiomyopathy: A Current View on the Pathophysiology, Diagnosis, and Treatment.

Krejci J, Mlejnek D, Sochorova D, Nemec P

BioMed research international 2016; (2016()):4087632 doi:10.1155/2016/4087632.

The appropriate dose of angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?

Ishida J, Konishi M, von Haehling S

ESC heart failure 2015; (2(4)):103-105 doi:10.1002/ehf2.12073.

Late Gadolinium Enhancement and the Risk for Ventricular Arrhythmias or Sudden Death in Dilated Cardiomyopathy: Systematic Review and Meta-Analysis.

Di Marco A, Anguera I, Schmitt M, et al.

JACC. Heart failure 2017; (5(1)):28-38 doi:10.1016/j.jchf.2016.09.017.

Biventricular endomyocardial biopsy in patients with suspected myocarditis: Feasibility, complication rate and additional diagnostic value.

Stiermaier T, Föhrenbach F, Klingel K, et al.

International journal of cardiology 2017; (230()):364-370 doi:10.1016/j.ijcard.2016.12.103.

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.

Duncker D, König T, Hohmann S, et al.

Journal of the American Heart Association 2017; (6(1)) doi:10.1161/JAHA.116.004512.

Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis.

Ammirati E, Cipriani M, Lilliu M, et al.

Circulation 2017; (136(6)):529-545 doi:10.1161/CIRCULATIONAHA.117.026386.

Extracorporeal membrane oxygenation in adult patients with acute fulminant myocarditis : Clinical outcomes and risk factor analysis.

Liao X, Li B, Cheng Z

Herz 2018; (43(8)):728-732 doi:10.1007/s00059-017-4617-7.

Inflammatory Cardiomyopathic Syndromes.

Trachtenberg BH, Hare JM

Circulation research 2017; (121(7)):803-818 doi:10.1161/CIRCRESAHA.117.310221.

Human herpesvirus 6-induced inflammatory cardiomyopathy in immunocompetent children.

Reddy S, Eliassen E, Krueger GR, Das BB

Annals of pediatric cardiology 2017; (10(3)):259-268 doi:10.4103/apc.APC_54_17.

[Myocarditis and inflammatory cardiomyopathy].

Mlejnek D, Krejčí J

Vnitrni lekarstvi 2017; (63(7-8)):507-512.

Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation.

Hasselberg NE, Haland TF, Saberniak J, et al.

European heart journal 2018; (39(10)):853-860 doi:10.1093/eurheartj/ehx596.

Therapeutic implications of a combined diagnostic workup including endomyocardial biopsy in an all-comer population of patients with heart failure: a retrospective analysis.

Sotiriou E, Heiner S, Jansen T, et al.

ESC heart failure 2018; (5(4)):630-641 doi:10.1002/ehf2.12296.

Clinical Presentation and Outcome in a Contemporary Cohort of Patients With Acute Myocarditis: Multicenter Lombardy Registry.

Ammirati E, Cipriani M, Moro C, et al.

Circulation 2018; (138(11)):1088-1099 doi:10.1161/CIRCULATIONAHA.118.035319.

Genetic Etiology for Alcohol-Induced Cardiac Toxicity.

Ware JS, Amor-Salamanca A, Tayal U, et al.

Journal of the American College of Cardiology 2018; (71(20)):2293-2302 doi:10.1016/j.jacc.2018.03.462.

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.

Crespo-Leiro MG, Metra M, Lund LH, et al.

European journal of heart failure 2018; (20(11)):1505-1535 doi:10.1002/ejhf.1236.

A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.

Horvat C, Johnson R, Lam L, et al.

Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(1)):133-143 doi:10.1038/s41436-018-0036-2.

Indications for and outcome in patients with the wearable cardioverter-defibrillator in a nurse-based training programme: results of the Austrian WCD Registry.

Odeneg T, Ebner C, Mörtl D, et al.

European journal of cardiovascular nursing 2019; (18(1)):75-83 doi:10.1177/1474515118790365.

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.

Halliday BP, Wassall R, Lota AS, et al.

Lancet (London, England) 2019; (393(10166)):61-73 doi:10.1016/S0140-6736(18)32484-X.

Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.

Ferreira VM, Schulz-Menger J, Holmvang G, et al.

Journal of the American College of Cardiology 2018; (72(24)):3158-3176 doi:10.1016/j.jacc.2018.09.072.

Enterovirus Persistence in Cardiac Cells of Patients With Idiopathic Dilated Cardiomyopathy Is Linked to 5' Terminal Genomic RNA-Deleted Viral Populations With Viral-Encoded Proteinase Activities.

Bouin A, Gretteau PA, Wehbe M, et al.

Circulation 2019; (139(20)):2326-2338 doi:10.1161/CIRCULATIONAHA.118.035966.

Change in renal function associated with drug treatment in heart failure: national guidance.

Clark AL, Kalra PR, Petrie MC, et al.

Heart (British Cardiac Society) 2019; (105(12)):904-910 doi:10.1136/heartjnl-2018-314158.

Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature.

Reichart D, Magnussen C, Zeller T, Blankenberg S

Journal of internal medicine 2019; (286(4)):362-372 doi:10.1111/joim.12944.

Patient Selection for Destination LVAD Therapy: Predicting Success in the Short and Long Term.

Michaels A, Cowger J

Current heart failure reports 2019; (16(5)):140-149 doi:10.1007/s11897-019-00434-1.

The effectiveness of cardiac rehabilitation in non-ischemic dilated cardiomyopathy patients: A pilot study.

Lin MT, Chen WC, Wu CH, et al.

Journal of the Formosan Medical Association = Taiwan yi zhi 2020; (119(2)):627-634 doi:10.1016/j.jfma.2019.08.018.

[Heart failure in old age : Current recommendations in view of the revised national treatment guidelines on chronic heart failure].

Lambrecht A, Hardt R

Zeitschrift fur Gerontologie und Geriatrie 2019; (52(7)):701-712 doi:10.1007/s00391-019-01617-0.

Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management.

Ali-Ahmed F, Dalgaard F, Al-Khatib SM

American heart journal 2020; (220()):29-40 doi:10.1016/j.ahj.2019.08.007.

Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement From the American Heart Association.

Kociol RD, Cooper LT, Fang JC, et al.

Circulation 2020; (141(6)):e69-e92 doi:10.1161/CIR.0000000000000745.

Rhinovirus-associated dilated cardiomyopathy.

Chow J, Murphy J, Subedi A, Jyothidasan A

IDCases 2020; (19()):e00702 doi:10.1016/j.idcr.2020.e00702.

The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis.

Yang F, Wang J, Li W, et al.

European radiology 2020; (30(5)):2616-2626 doi:10.1007/s00330-019-06643-5.

Dilated cardiomyopathies and non-compaction cardiomyopathy.

Hänselmann A, Veltmann C, Bauersachs J, Berliner D

Herz 2020; (45(3)):212-220 doi:10.1007/s00059-020-04903-5.

Viral Myocarditis-Incidence, Diagnosis and Management.

Olejniczak M, Schwartz M, Webber E, et al.

Journal of cardiothoracic and vascular anesthesia 2020; (34(6)):1591-1601 doi:10.1053/j.jvca.2019.12.052.

Recent Advances in T1 and T2 Mapping in the Assessment of Fulminant Myocarditis by Cardiac Magnetic Resonance.

Wheen P, Armstrong R, Daly CA

Current cardiology reports 2020; (22(7)):47 doi:10.1007/s11886-020-01295-0.

Viral presence-guided immunomodulation in lymphocytic myocarditis: an update.

Sinagra G, Porcari A, Gentile P, et al.

European journal of heart failure 2021; (23(2)):211-216 doi:10.1002/ejhf.1969.

A case of chronic myocarditis.

Kawano H, Iyama K, Abe K, et al.

Pathology international 2020; (70(10)):793-797 doi:10.1111/pin.12989.

[IRM et myocardite infectieuse].

Sanguineti F, Garot J, Hovasse T, et al.

Annales de cardiologie et d'angeiologie 2020; (69(6)):418-423 doi:10.1016/j.ancard.2020.09.043.

Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis.

Trpkov C, MacMullan P, Feuchter P, et al.

CJC open 2021; (3(2)):210-213 doi:10.1016/j.cjco.2020.10.003.

Considering complexity in the genetic evaluation of dilated cardiomyopathy.

Jordan E, Hershberger RE

Heart (British Cardiac Society) 2021; (107(2)):106-112 doi:10.1136/heartjnl-2020-316658.

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy: An Expert Consensus Document.

Ammirati E, Frigerio M, Adler ED, et al.

Circulation. Heart failure 2020; (13(11)):e007405 doi:10.1161/CIRCHEARTFAILURE.120.007405.

The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape.

Wong JA, Roberts JD, Healey JS

The Canadian journal of cardiology 2021; (37(4)):644-654 doi:10.1016/j.cjca.2021.01.024.

Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week.

Bang V, Ganatra S, Shah SP, et al.

Journal of the American College of Cardiology 2021; (77(8)):1122-1134 doi:10.1016/j.jacc.2020.11.074.

Genetics of dilated cardiomyopathy.

Chen SN, Mestroni L, Taylor MRG

Current opinion in cardiology 2021; (36(3)):288-294 doi:10.1097/HCO.0000000000000845.

The Time Has Come to Explore Plasma Biomarkers in Genetic Cardiomyopathies.

Stege NM, de Boer RA, van den Berg MP, Silljé HHW

International journal of molecular sciences 2021; (22(6)) doi:10.3390/ijms22062955.

The State of the Heart Biopsy: A Clinical Review.

Kiamanesh O, Toma M

CJC open 2021; (3(4)):524-531 doi:10.1016/j.cjco.2020.11.017.

Improved Risk Stratification for Ventricular Arrhythmias and Sudden Death in Patients With Nonischemic Dilated Cardiomyopathy.

Di Marco A, Brown PF, Bradley J, et al.

Journal of the American College of Cardiology 2021; (77(23)):2890-2905 doi:10.1016/j.jacc.2021.04.030.

Clinically Suspected and Biopsy-Proven Myocarditis Temporally Associated with SARS-CoV-2 Infection.

Caforio ALP, Baritussio A, Basso C, Marcolongo R

Annual review of medicine 2022; (73()):149-166 doi:10.1146/annurev-med-042220-023859.

When is a wearable defibrillator indicated?

Bodin A, Bisson A, Fauchier L

Expert review of medical devices 2021; (18(sup1)):51-56 doi:10.1080/17434440.2021.2019013.

Fatal human herpes virus 6B myocarditis: Postmortem diagnosis of HHV-6B based on CD134+ T-cell tropism.

Yamada A, Takeichi T, Kiryu K, et al.

Legal medicine (Tokyo, Japan) 2022; (54()):102007 doi:10.1016/j.legalmed.2021.102007.

The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention.

Elsanhoury A, Kühl U, Stautner B, et al.

Viruses 2022; (14(2)) doi:10.3390/v14020299.

Fulminant myocarditis in adults: a narrative review.

Montero S, Abrams D, Ammirati E, et al.

Journal of geriatric cardiology : JGC 2022; (19(2)):137-151 doi:10.11909/j.issn.1671-5411.2022.02.006.

Viral Myocarditis: Classification, Diagnosis, and Clinical Implications.

Sozzi FB, Gherbesi E, Faggiano A, et al.

Frontiers in cardiovascular medicine 2022; (9()):908663 doi:10.3389/fcvm.2022.908663.

Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial.

Chimenti C, Russo MA, Frustaci A

European heart journal 2022; (43(36)):3463-3473 doi:10.1093/eurheartj/ehac348.

Parametric Mapping Cardiac Magnetic Resonance Imaging for the Diagnosis of Myocarditis in Children in the Era of COVID-19 and MIS-C.

Das BB, Akam-Venkata J, Abdulkarim M, Hussain T

Children (Basel, Switzerland) 2022; (9(7)) doi:10.3390/children9071061.

Genetic Architecture of Acute Myocarditis and the Overlap With Inherited Cardiomyopathy.

Lota AS, Hazebroek MR, Theotokis P, et al.

Circulation 2022; (146(15)):1123-1134 doi:10.1161/CIRCULATIONAHA.121.058457.

Guideline Directed Medical Therapy at Discharge and Further Uptitration Leading to Reduction in Indication for Prophylactic ICD Implantation during Protected Waiting Period.

Waezsada E, Hutter J, Kahle P, et al.

Journal of clinical medicine 2022; (11(20)) doi:10.3390/jcm11206122.

Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update.

Mavrogeni S, Pepe A, Gargani L, et al.

Seminars in arthritis and rheumatism 2023; (58()):152126 doi:10.1016/j.semarthrit.2022.152126.

Development of dilated cardiomyopathy with a long latent period followed by viral fulminant myocarditis: A case report.

Lee SD, Lee HJ, Kim HR, et al.

World journal of clinical cases 2022; (10(36)):13451-13457 doi:10.12998/wjcc.v10.i36.13451.

The Heart Failure Optimization Study (HF-OPT): rationale and design.

Sanchez R, Duncker D, Colley B, et al.

Herzschrittmachertherapie & Elektrophysiologie 2023; (34(1)):52-58 doi:10.1007/s00399-022-00920-5.

Cardiac Resynchronization Therapy Improves Outcomes in Patients With Intraventricular Conduction Delay But Not Right Bundle Branch Block: A Patient-Level Meta-Analysis of Randomized Controlled Trials.

Friedman DJ, Al-Khatib SM, Dalgaard F, et al.

Circulation 2023; (147(10)):812-823 doi:10.1161/CIRCULATIONAHA.122.062124.

Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction.

Krittanawong C, Rodriguez M, Lui M, et al.

The American journal of medicine 2023; (136(5)):422-431 doi:10.1016/j.amjmed.2023.01.024.

Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review.

Guglin ME, Etuk A, Shah C, Ilonze OJ

Journal of clinical medicine 2023; (12(5)) doi:10.3390/jcm12051849.

Association of late gadolinium enhancement in cardiac magnetic resonance with mortality, ventricular arrhythmias, and heart failure in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.

Al-Sadawi M, Aslam F, Tao M, et al.

Heart rhythm O2 2023; (4(4)):241-250 doi:10.1016/j.hroo.2023.01.001.

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies.

Aquaro GD, De Gori C, Faggioni L, et al.

European heart journal supplements : journal of the European Society of Cardiology 2023; (25(Suppl C)):C130-C136 doi:10.1093/eurheartjsupp/suad015.

Remote monitoring titration clinic to implement guideline-directed therapy for heart failure patients with reduced ejection fraction: a pilot quality-improvement intervention.

Romero E, Yala S, Sellers-Porter C, et al.

Frontiers in cardiovascular medicine 2023; (10()):1202615 doi:10.3389/fcvm.2023.1202615.

Impact of late gadolinium-enhanced cardiac MRI on arrhythmic and mortality outcomes in nonischemic dilated cardiomyopathy: updated systematic review and meta-analysis.

Theerasuwipakorn N, Chokesuwattanaskul R, Phannajit J, et al.

Scientific reports 2023; (13(1)):13775 doi:10.1038/s41598-023-41087-4.

Fulminant myocarditis proven by early biopsy and outcomes.

Huang F, Ammirati E, Ponnaiah M, et al.

European heart journal 2023; (44(48)):5110-5124 doi:10.1093/eurheartj/ehad707.

CD4+TEM cells drive the progression from acute myocarditis to dilated cardiomyopathy in CVB3-induced BALB/c mice.

Huang Y, Huang X, Wei Z, et al.

International immunopharmacology 2024; (127()):111304 doi:10.1016/j.intimp.2023.111304.

Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis.

Uccello G, Bonacchi G, Rossi VA, et al.

Journal of clinical medicine 2023; (13(1)) doi:10.3390/jcm13010150.

Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy.

Setti M, Merlo M, Gigli M, et al.

European journal of heart failure 2024; (26(3)):581-589 doi:10.1002/ejhf.3168.

Multidisciplinary approach to long-standing left bundle branch block with dyssynchrony and aortic stenosis: case report.

Maigrot JA, Weiss AJ, Wazni O, Starling RC

European heart journal. Case reports 2024; (8(4)):ytae127 doi:10.1093/ehjcr/ytae127.

Therapy duration and improvement of ventricular function in de novo heart failure: the Heart Failure Optimization study.

Veltmann C, Duncker D, Doering M, et al.

European heart journal 2024; (45(30)):2771-2781 doi:10.1093/eurheartj/ehae334.

Viral Myocarditis as a Factor Leading to the Development of Heart Failure Symptoms, Including the Role of Parvovirus B19 Infection-Systematic Review.

Krych S, Jęczmyk A, Jurkiewicz M, et al.

International journal of molecular sciences 2024; (25(15)) doi:10.3390/ijms25158127.

Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?

Hu JR, Schwann AN, Tan JW, et al.

Heart failure clinics 2024; (20(4)):373-386 doi:10.1016/j.hfc.2024.06.004.

Prescription Patterns in Management of Heart Failure and Its Association With Readmissions: A Retrospective Analysis.

Agrawal S, Alhaddad Z, Nabia S, et al.

Journal of cardiac failure 2025; (31(4)):635-645 doi:10.1016/j.cardfail.2024.08.059.

Prognostic Implications of Clinical and Imaging Diagnostic Criteria for Myocarditis.

Bernhard B, Marxer ME, Zurkirchen JC, et al.

Journal of the American College of Cardiology 2024; (84(15)):1373-1387 doi:10.1016/j.jacc.2024.07.018.

Trajectories following Impella 5.5 support are associated with initial presentation acuity.

Maigrot JA, Starling RC, Soltesz EG, et al.

Artificial organs 2025; (49(1)):137-145 doi:10.1111/aor.14867.

Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization.

Dixit NM, Shah S, Ziaeian B, et al.

US cardiology 2021; (15()):e07 doi:10.15420/usc.2020.29.

Mitochondrial injury and complement dysregulation are drivers of pathological inflammation in viral myocarditis.

Mohamud Y, Bahreyni A, Hwang SW, et al.

Journal of virology 2025; (99(2)):e0180424 doi:10.1128/jvi.01804-24.

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy.

Feng XY, Zheng YC, Yang YX, et al.

Reviews in cardiovascular medicine 2025; (26(1)):25654 doi:10.31083/RCM25654.

Discovery of miRNAs unique to actively transcribed erythroparvovirus infection in heart failure patients.

Aleshcheva G, Salih S, Baumeier C, et al.

ESC heart failure 2025; (12(3)):1872-1882 doi:10.1002/ehf2.15194.

Acute myocarditis: 2024 state of the art.

Ammirati E, Cartella I, Varrenti M, et al.

European heart journal supplements : journal of the European Society of Cardiology 2025; (27(Suppl 1)):i56-i60 doi:10.1093/eurheartjsupp/suae105.

Revisiting Secondary Dilative Cardiomyopathy.

Kundnani NR, Di Luca F, Meche V, et al.

International journal of molecular sciences 2025; (26(9)) doi:10.3390/ijms26094181.

Immunosuppressive therapy in patients with biopsy-proven inflammatory myocardial disease: a systematic review and meta-analysis.

Stautner B, Tkaczyszyn M, Sorg A, et al.

Scientific reports 2025; (15(1)):37173 doi:10.1038/s41598-025-25165-3.

Early clinical predictors of fulminant myocarditis in pediatric patients: a retrospective cohort study.

Yuan J, Li M, Ma L, et al.

Frontiers in cardiovascular medicine 2025; (12()):1678220 doi:10.3389/fcvm.2025.1678220.

Heart failure with reduced ejection fraction.

Cannata A, Crespo-Leiro MG, Bromage DI, et al.

Lancet (London, England) 2026; (407(10527)):529-542 doi:10.1016/S0140-6736(25)01851-3.

Digital Platform to Optimize Guideline-Directed Heart Failure Therapy: Results of the AIM-POWER Trial.

DeVore AD, Majmudar M, Etters L, et al.

Circulation. Heart failure 2026; (19(2)):e013231 doi:10.1161/CIRCHEARTFAILURE.125.013231.

Successful VA-ECMO rescue of life-threatening cardiotoxicity following paclitaxel and cisplatin neoadjuvant chemotherapy for laryngeal cancer: a case report.

Qian Y, Pan Y, Che Z, et al.

BMC cardiovascular disorders 2025; (26(1)):51 doi:10.1186/s12872-025-05440-x.

Myocarditis and pericarditis in focus: A critical appraisal of the 2025 ESC vs ACC position statements from the Italian society of cardiology working group on cardiomyopathies and pericardial diseases.

Imazio M, Collini V, Merlo M, et al.

Trends in cardiovascular medicine 2026; (36(5)):317-326 doi:10.1016/j.tcm.2026.01.002.

Diagnostic and Therapeutic Options in Myocarditis and Inflammatory Cardiomyopathy.

Schultheiss HP, Escher F, Aleshcheva G, et al.

Biomedicines 2026; (14(3)) doi:10.3390/biomedicines14030691.

Post-viral myocarditis.

Sokolski M, Zychla W, Wilk M, et al.

Heart failure reviews 2026; (31(1)).

Homozygous PPP1R13L Mutation Associated with Dilated Cardiomyopathy in a 1-Year-Old Child.

Sorescu AM, Ghiță CIV, Duică G, et al.

Life (Basel, Switzerland) 2026; (16(8)) doi:10.3390/life16081229.

Workup and management of rhythm disorders in myocarditis and inflammatory cardiomyopathy: a clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC, the ESC Working Group on Myocardial & Pericardial Diseases, the European Association of Preventive Cardiology of the ESC, the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society, and the Latin American Heart Rhythm Society.

Peretto G, Basso C, Berruezo A, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2026; (28(8)) doi:10.1093/europace/euag153.